Come up with a name for your new list and we'll add to it:
20/20 GeneSystems raised a round of funding on September 09, 2002. Investors include
Maryland Technology Development Corporation.
20/20 GeneSystems has developed, validated, and undergone clinical testing of a blood test for the early detection of lung cancer. The test measures a panel of tumor biomarkers and utilizes a propriet…